← back to search

Yaoxing Dou

Guangzhou University of Chinese Medicine · CN
🔎 Find collaborators in Molecular Biology · Pharmacology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Pharmacology
Research interest
Research interests include Pharmacology, Chemistry, Medicine, Colitis, Oxidative stress, and Inflammation.
h-index
citations
1,272
works
36
NIH funding
primary concept
email

Recent publications

Protective Effects of Oxyberberine Against Hyperuricemic Nephropathy: Mechanistic Insights From In Silico, In Vitro, and In Vivo Studies
Phytotherapy Research 2026cited by 0position: middledoi
A Hepatic Oxidative Metabolite of Palmatine Ameliorates DSS-Induced Ulcerative Colitis by Regulating Macrophage Polarization Through AMPK/NF-κB Pathway
The American Journal of Chinese Medicine 2025cited by 5position: middledoi
Unveiling the sweet culprit: Excessive fructose intake leading to kidney injury through hypoxanthine accumulation
Journal of Functional Foods 2025cited by 0position: lastdoi
Transcriptomic analyses and machine-learning methods reveal dysregulated key genes and potential pathogenesis in human osteoarthritic cartilage
Bone and Joint Research 2024cited by 12position: middledoi
Enhancing hepatoprotective action: oxyberberine amorphous solid dispersion system targeting TLR4
Scientific Reports 2024cited by 8position: lastdoi
Mitigation of inflammatory bowel disease-related osteoporosis by oxyberberine: Insights into the RANKL/NF-κB signaling pathway
Biomedicine & Pharmacotherapy 2024cited by 7position: lastdoi
Research progress of plant medicine and Chinese herbal compounds in the treatment of rheumatoid arthritis combined with osteoporosis
Frontiers in Medicine 2024cited by 7position: lastdoi
Improvement effects of a novel Chinese herbal formula in imiquimod and IL-23-stimulated mouse models of psoriasis
Chinese Medicine 2024cited by 6position: middledoi
Liuwei Dihuang Pills Enhance Osteogenic Differentiation in MC3T3-E1 Cells through the Activation of the Wnt/β-Catenin Signaling Pathway
Pharmaceuticals 2024cited by 4position: middledoi
The effects of extracellular matrix‐degrading enzymes polymorphisms on intervertebral disc degeneration
JOR Spine 2024cited by 2position: middledoi
Natural Nrf2 Inhibitors: A Review of Their Potential for Cancer Treatment
International Journal of Biological Sciences 2023cited by 61position: middledoi
Higher systemic immune-inflammation index is associated with sarcopenia in individuals aged 18–59 years: a population-based study
Scientific Reports 2023cited by 29position: middledoi
Network pharmacology identifies fisetin as a treatment for osteoporosis that activates the Wnt/β-catenin signaling pathway in BMSCs
Journal of Orthopaedic Surgery and Research 2023cited by 9position: middledoi
J-shaped association of serum uric acid concentrations with all-cause mortality in individuals with osteoarthritis: A prospective cohort study
Joint Bone Spine 2023cited by 6position: middledoi
Global Publication Trends and Research Hotspots of the Immune Systemand Osteoporosis: A Bibliometric and Visualization Analysis from 2012 to2022
Endocrine Metabolic & Immune Disorders - Drug Targets 2023cited by 5position: middledoi
Longbie capsules reduce bone loss in the subchondral bone of rats with comorbid osteoporosis and osteoarthritis by regulating metabolite alterations
Frontiers in Medicine 2023cited by 4position: middledoi
Mechanism and Experimental Verification of Luteolin for the Treatment of Osteoporosis Based on Network Pharmacology
Frontiers in Endocrinology 2022cited by 52position: middledoi
Major Constituents From Brucea javanica and Their Pharmacological Actions
Frontiers in Pharmacology 2022cited by 43position: middledoi
Hypouricemic and nephroprotective effects of palmatine from Cortex Phellodendri Amurensis: A uric acid modulator targeting Keap1-Nrf2/NLRP3 axis
Journal of Ethnopharmacology 2022cited by 37position: lastdoi
Oxyberberine, a novel HO-1 agonist, effectively ameliorates oxidative stress and inflammatory response in LPS/D-GalN induced acute liver injury mice via coactivating erythrocyte metabolism and Nrf2 signaling pathway
Food and Chemical Toxicology 2022cited by 29position: middledoi
In vitro and in vivo hypoglycemia effect of oxyberberine, a novel HO-1 agonist: A renewed evidence linking HO-1 to diabetes mellitus
Phytomedicine 2022cited by 20position: firstdoi
Quercetin enhances survival and axonal regeneration of motoneurons after spinal root avulsion and reimplantation: experiments in a rat model of brachial plexus avulsion
Inflammation and Regeneration 2022cited by 8position: middledoi
Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways
Biomedicine & Pharmacotherapy 2021cited by 85position: firstdoi
Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats
Phytomedicine 2021cited by 53position: middledoi
The anti-hepatocellular carcinoma effect of Brucea javanica oil in ascitic tumor-bearing mice: The detection of brusatol and its role
Biomedicine & Pharmacotherapy 2020cited by 30position: middledoi
Therapeutic effect of Brucea javanica oil emulsion on experimental Crohn’s disease in rats: Involvement of TLR4/ NF-κB signaling pathway
Biomedicine & Pharmacotherapy 2019cited by 26position: middledoi
Palmatine ameliorated murine colitis by suppressing tryptophan metabolism and regulating gut microbiota
Pharmacological Research 2018cited by 177position: middledoi
Prophylactic efficacy of patchoulene epoxide against ethanol-induced gastric ulcer in rats: Influence on oxidative stress, inflammation and apoptosis
Chemico-Biological Interactions 2018cited by 69position: middledoi
Self-nanoemulsfiying drug delivery system of bruceine D: a new approach for anti-ulcerative colitis
International Journal of Nanomedicine 2018cited by 66position: firstdoi
Brusatol ameliorates 2, 4, 6-trinitrobenzenesulfonic acid-induced experimental colitis in rats: Involvement of NF-κB pathway and NLRP3 inflammasome
International Immunopharmacology 2018cited by 54position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ziren Su · Guangzhou University of Chinese Medicine20 papers (2017–2025)Jianhui Xie · Guangzhou University of Chinese Medicine10 papers (2017–2025)Lingfeng Zeng · Guangzhou University of Chinese Medicine10 papers (2022–2024)Guihong Liang · Guangzhou University of Chinese Medicine9 papers (2022–2024)Gaoxiang Ai · Guangzhou University of Chinese Medicine8 papers (2021–2026)Jiannan Chen · Ningbo University8 papers (2018–2025)Zhi‐Xiu Lin · Chinese University of Hong Kong8 papers (2017–2023)Huifang Zeng · Guangzhou University of Chinese Medicine7 papers (2017–2021)Weiyi Yang · Guangzhou University of Chinese Medicine7 papers (2023–2024)Yan‐Fang Xian · Third Affiliated Hospital of Sun Yat-sen University6 papers (2017–2024)Qionghui Huang · Guangzhou University of Chinese Medicine6 papers (2017–2022)Jinlong Zhao · Guangzhou University of Chinese Medicine6 papers (2023–2024)Yucui Li · Guangzhou University of Chinese Medicine6 papers (2017–2025)Yuhong Liu · Guangzhou University of Chinese Medicine6 papers (2017–2022)Jun Liu · Guangzhou University of Chinese Medicine6 papers (2023–2024)Youliang Xie · Guangzhou University of Chinese Medicine6 papers (2017–2025)Chang Qu · Guangzhou University of Chinese Medicine6 papers (2017–2022)Jiangtao Zhou · Guangzhou University of Chinese Medicine5 papers (2017–2018)Hetao Huang · Guangzhou University of Chinese Medicine5 papers (2023–2024)Guanghui Zhou · Guangzhou University of Chinese Medicine5 papers (2023–2024)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Pharmacology →